| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer | Chief Medical Officer
1 company
Tanimoto Sarina is a Chief Medical Officer at ARS Pharmaceuticals, Inc.. Recent SEC Form 4 filings include 0 buys and 27 sells.
Estimated insider holdings value: $12.0M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 20, 2025 | SPRY Ars Pharmaceuticals, Inc. | Chief Medical Officer | Sell | 50,000 | $14.08 | $703,755.30 | -1.9% | -51.5% | - | |
| Dec 17, 2024 | SPRY Ars Pharmaceuticals, Inc. | Chief Medical Officer | Sell | 100,000 | $11.67 | $1,167,100.00 | -4.0% | -2.7% | -14.4% | |
| Dec 10, 2024 | SPRY Ars Pharmaceuticals, Inc. | Chief Medical Officer | Sell | 100,000 | $13.16 | $1,316,420.00 | -4.0% | -16.4% | -19.4% | |
| Nov 19, 2024 | SPRY Ars Pharmaceuticals, Inc. | Chief Medical Officer | Sell | 100,000 | $13.95 | $1,394,960.00 | -3.8% | -14.6% | -48.6% | |
| Nov 12, 2024 | SPRY Ars Pharmaceuticals, Inc. | Chief Medical Officer | Sell | 100,000 | $16.85 | $1,684,642.45 | -1.9% | -29.3% | -46.1% | |
| Oct 15, 2024 | SPRY Ars Pharmaceuticals, Inc. | Chief Medical Officer | Sell | 100,000 | $14.88 | $1,487,595.07 | -2.4% | -26.1% | -28.0% | |
| Oct 8, 2024 | SPRY Ars Pharmaceuticals, Inc. | Chief Medical Officer | Sell | 100,000 | $13.83 | $1,382,775.00 | -3.6% | -20.2% | -20.0% | |
| Sep 17, 2024 | SPRY Ars Pharmaceuticals, Inc. | Chief Medical Officer | Sell | 100,000 | $12.93 | $1,293,205.00 | -3.4% | -8.9% | -26.7% | |
| Sep 10, 2024 | SPRY Ars Pharmaceuticals, Inc. | Chief Medical Officer | Sell | 100,000 | $11.50 | $1,149,775.00 | -3.4% | +15.6% | -8.8% | |
| Aug 20, 2024 | SPRY Ars Pharmaceuticals, Inc. | Chief Medical Officer | Sell | 100,000 | $15.03 | $1,502,586.52 | -1.1% | -7.5% | -1.9% |